Zero Candida Announces First Intellectual Property in South Africa

Company is in the process to be listed on the TSX Venture Exchange (Canada) at a Proposed Valuation of 40 million Canadian Dollars

TEL AVIV, IsraelJune 18, 2024 /CNW/ — Zero Candida (the “Company” or “ZC “) an Israeli FemTech medical device start-up is pleased to announce its first INTELLECTUAL PROPERTY – 2022/09265 Granted + PCT patent PCT-IL 2023050243 in South Africa.

Are you an angel?

Public Announcements

Zero Candida Receives South African Patent for its ZC- 01 device

VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ — Zero Candida (the “Company” or “ZC”) (TSXV: ZCT), an Israeli FemTech medical device start-up, is pleased to announce…

Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada)

VANCOUVER, BC, Nov. 25, 2024 /PRNewswire/ — Zero Candida (the “Company” or “ZCT”), (TSXV: ZCT) an Israeli FemTech medical device start-up, is pleased to announce…

Zero Candida Announces TSX Venture Exchange Listing Date

Zero Candida (formerly 1319743 B.C. Ltd.), has recently completed its business acquisition of Zero Candida Ltd., an Israeli private company (“ZC” and “Acquisition” respectively). In…